Nina B. Shapiro - Net Worth and Insider Trading

Nina B. Shapiro Net Worth

The estimated net worth of Nina B. Shapiro is at least $495,641 dollars as of 2024-11-13. Nina B. Shapiro is the Director of Identiv Inc and owns about 137,747 shares of Identiv Inc (INVE) stock worth over $495,641. Details can be seen in Nina B. Shapiro's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nina B. Shapiro has not made any transactions after 2020-12-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Nina B. Shapiro

Nina B. Shapiro Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nina B. Shapiro owns 5 companies in total, including Identiv Inc (INVE) , Tenzing Acquisition Corp (TZACU) , and Eucrates Biomedical Acquisition Corp (EUCRU) among others .

Click here to see the complete history of Nina B. Shapiro’s form 4 insider trades.

Insider Ownership Summary of Nina B. Shapiro

Ticker	Comapny	Transaction Date	Type of Owner
INVE	Identiv Inc	2020-12-11	director
TZACU	Tenzing Acquisition Corp	2018-08-20	director
EUCRU	Eucrates Biomedical Acquisition Corp	2020-10-23	director
		2018-08-20	director
		2020-10-23	director

Nina B. Shapiro Latest Holdings Summary

Nina B. Shapiro currently owns a total of 1 stock. Nina B. Shapiro owns 137,747 shares of Identiv Inc (INVE) as of December 11, 2020, with a value of $495,641.

Latest Holdings of Nina B. Shapiro

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
INVE	Identiv Inc	2020-12-11	137,747	3.60	495,641

Holding Weightings of Nina B. Shapiro

Nina B. Shapiro Form 4 Trading Tracker

According to the SEC Form 4 filings, Nina B. Shapiro has made a total of 2 transactions in Identiv Inc (INVE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Identiv Inc is the sale of 15,000 shares on December 11, 2020, which brought Nina B. Shapiro around $110,700.

Insider Trading History of Nina B. Shapiro

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nina B. Shapiro Trading Performance

GuruFocus tracks the stock performance after each of Nina B. Shapiro's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nina B. Shapiro is -16.26%. GuruFocus also compares Nina B. Shapiro's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nina B. Shapiro within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nina B. Shapiro's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nina B. Shapiro

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.99
Relative Return to S&P 500(%)	6.11

Nina B. Shapiro Ownership Network

Ownership Network List of Nina B. Shapiro

No Data

Ownership Network Relation of Nina B. Shapiro

Nina B. Shapiro Owned Company Details

What does Identiv Inc do?

Who are the key executives at Identiv Inc?

Nina B. Shapiro is the director of Identiv Inc. Other key executives at Identiv Inc include director & CEO Steven Humphreys , 10 percent owner Bleichroeder Lp , and Chief Financial Officer Justin Scarpulla .

Identiv Inc (INVE) Insider Trades Summary

Over the past 18 months, Nina B. Shapiro made no insider transaction in Identiv Inc (INVE). Other recent insider transactions involving Identiv Inc (INVE) include a net purchase of 35,000 shares made by Steven Humphreys , a net purchase of 25,000 shares made by Gary Kremen , and a net purchase of 17,166 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Identiv Inc (INVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Identiv Inc (INVE) were sold and 77,166 shares were bought by its insiders, resulting in a net purchase of 77,166 shares.

Identiv Inc (INVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Identiv Inc Insider Transactions

No Available Data

What does Tenzing Acquisition Corp do?

Who are the key executives at Tenzing Acquisition Corp?

Nina B. Shapiro is the director of Tenzing Acquisition Corp. Other key executives at Tenzing Acquisition Corp include 10 percent owner Glazer Capital, Llc , 10 percent owner Paul J Glazer , and 10 percent owner Mizuho Securities Usa Llc .

Tenzing Acquisition Corp (TZACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tenzing Acquisition Corp (TZACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenzing Acquisition Corp (TZACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tenzing Acquisition Corp (TZACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tenzing Acquisition Corp Insider Transactions

No Available Data

What does Eucrates Biomedical Acquisition Corp do?

Who are the key executives at Eucrates Biomedical Acquisition Corp?

Nina B. Shapiro is the director of Eucrates Biomedical Acquisition Corp. Other key executives at Eucrates Biomedical Acquisition Corp include director & 10 percent owner Stelios Papadopoulos , director & 10 percent owner & Chief Executive Officer Parag Saxena , and Vice President Atanuu Agarrwal .

Eucrates Biomedical Acquisition Corp (EUCRU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eucrates Biomedical Acquisition Corp (EUCRU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eucrates Biomedical Acquisition Corp (EUCRU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eucrates Biomedical Acquisition Corp (EUCRU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eucrates Biomedical Acquisition Corp Insider Transactions

No Available Data

What does Reviva Pharmaceuticals Holdings Inc do?

Who are the key executives at Reviva Pharmaceuticals Holdings Inc?

Nina B. Shapiro is the director of Reviva Pharmaceuticals Holdings Inc. Other key executives at Reviva Pharmaceuticals Holdings Inc include Chief Financial Officer Narayan Parbhu , director & 10 percent owner Parag Saxena , and 10 percent owner Vedanta Partners, Llc .

Reviva Pharmaceuticals Holdings Inc (RVPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reviva Pharmaceuticals Holdings Inc (RVPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reviva Pharmaceuticals Holdings Inc (RVPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reviva Pharmaceuticals Holdings Inc (RVPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reviva Pharmaceuticals Holdings Inc Insider Transactions

No Available Data

What does Eucrates Biomedical Acquisition Corp do?

Who are the key executives at Eucrates Biomedical Acquisition Corp?

Eucrates Biomedical Acquisition Corp (EUCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eucrates Biomedical Acquisition Corp (EUCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eucrates Biomedical Acquisition Corp (EUCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eucrates Biomedical Acquisition Corp (EUCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eucrates Biomedical Acquisition Corp Insider Transactions

No Available Data

Nina B. Shapiro Mailing Address

Above is the net worth, insider trading, and ownership report for Nina B. Shapiro. You might contact Nina B. Shapiro via mailing address: 2201 Walnut Avenue, Suite 100, Fremont Ca 94538.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.